 Kendall Hunter
Concepts (282)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Artery | 32 | 2022 | 1063 | 4.120 |
Why?
| | Hypertension, Pulmonary | 37 | 2023 | 1794 | 3.550 |
Why?
| | Ventricular Dysfunction, Right | 14 | 2023 | 228 | 3.480 |
Why?
| | Ventricular Function, Right | 19 | 2023 | 257 | 3.090 |
Why?
| | Heart Ventricles | 21 | 2023 | 727 | 2.950 |
Why?
| | Vascular Stiffness | 25 | 2023 | 425 | 2.650 |
Why?
| | Models, Cardiovascular | 13 | 2020 | 180 | 1.900 |
Why?
| | Pulmonary Circulation | 13 | 2022 | 424 | 1.590 |
Why?
| | Stroke Volume | 14 | 2021 | 512 | 1.410 |
Why?
| | Magnetic Resonance Imaging, Cine | 11 | 2023 | 154 | 1.330 |
Why?
| | Blood Pressure | 12 | 2021 | 1664 | 1.180 |
Why?
| | Arterial Pressure | 5 | 2019 | 99 | 1.090 |
Why?
| | Vascular Resistance | 11 | 2022 | 356 | 1.060 |
Why?
| | Hemodynamics | 15 | 2022 | 1003 | 1.050 |
Why?
| | Echocardiography, Three-Dimensional | 2 | 2023 | 53 | 1.030 |
Why?
| | Cardiac Catheterization | 13 | 2021 | 541 | 1.010 |
Why?
| | Echocardiography | 9 | 2023 | 556 | 0.970 |
Why?
| | Imaging, Three-Dimensional | 4 | 2013 | 499 | 0.930 |
Why?
| | Phantoms, Imaging | 2 | 2014 | 139 | 0.890 |
Why?
| | Magnetic Resonance Angiography | 4 | 2019 | 210 | 0.850 |
Why?
| | Blood Flow Velocity | 8 | 2019 | 327 | 0.830 |
Why?
| | Magnetic Resonance Imaging | 11 | 2023 | 3174 | 0.810 |
Why?
| | Fontan Procedure | 5 | 2023 | 154 | 0.800 |
Why?
| | Forecasting | 1 | 2021 | 353 | 0.710 |
Why?
| | Carotid Arteries | 3 | 2018 | 184 | 0.650 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2017 | 65 | 0.620 |
Why?
| | Computer Simulation | 9 | 2019 | 922 | 0.590 |
Why?
| | Aorta, Thoracic | 6 | 2023 | 248 | 0.560 |
Why?
| | Echinococcosis, Pulmonary | 1 | 2015 | 6 | 0.550 |
Why?
| | Collagen | 6 | 2014 | 433 | 0.530 |
Why?
| | Elastic Modulus | 4 | 2013 | 118 | 0.510 |
Why?
| | Aorta | 6 | 2020 | 367 | 0.510 |
Why?
| | Child | 32 | 2023 | 19129 | 0.480 |
Why?
| | Fetal Growth Retardation | 3 | 2013 | 468 | 0.470 |
Why?
| | Portal Vein | 1 | 2014 | 90 | 0.450 |
Why?
| | Male | 48 | 2023 | 57801 | 0.450 |
Why?
| | Heart-Assist Devices | 4 | 2021 | 485 | 0.440 |
Why?
| | Industry | 1 | 2013 | 69 | 0.440 |
Why?
| | Cattle | 10 | 2023 | 978 | 0.430 |
Why?
| | Pulmonary Valve Insufficiency | 1 | 2012 | 36 | 0.430 |
Why?
| | Tetralogy of Fallot | 1 | 2012 | 79 | 0.420 |
Why?
| | Placental Insufficiency | 1 | 2013 | 104 | 0.410 |
Why?
| | Diagnostic Imaging | 1 | 2014 | 294 | 0.390 |
Why?
| | Humans | 63 | 2023 | 118972 | 0.390 |
Why?
| | Adolescent | 24 | 2022 | 18480 | 0.380 |
Why?
| | Extracellular Matrix | 5 | 2021 | 446 | 0.380 |
Why?
| | Blood Pressure Determination | 2 | 2008 | 133 | 0.370 |
Why?
| | Female | 43 | 2023 | 61564 | 0.370 |
Why?
| | Pulse Wave Analysis | 6 | 2023 | 216 | 0.370 |
Why?
| | Elasticity | 6 | 2015 | 193 | 0.370 |
Why?
| | Heart Defects, Congenital | 3 | 2018 | 703 | 0.370 |
Why?
| | Myocardial Contraction | 4 | 2020 | 339 | 0.370 |
Why?
| | Predictive Value of Tests | 9 | 2023 | 1868 | 0.370 |
Why?
| | Ventricular Function, Left | 5 | 2023 | 468 | 0.360 |
Why?
| | Heart Failure | 5 | 2023 | 1969 | 0.360 |
Why?
| | Ultrasonography | 1 | 2013 | 716 | 0.340 |
Why?
| | Fetus | 1 | 2013 | 690 | 0.330 |
Why?
| | Hypoxia | 4 | 2023 | 963 | 0.330 |
Why?
| | Aortic Diseases | 2 | 2021 | 94 | 0.330 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2021 | 709 | 0.330 |
Why?
| | Stress, Physiological | 1 | 2012 | 415 | 0.330 |
Why?
| | Hypoplastic Left Heart Syndrome | 2 | 2020 | 112 | 0.330 |
Why?
| | Image Interpretation, Computer-Assisted | 4 | 2018 | 220 | 0.320 |
Why?
| | Stress, Mechanical | 9 | 2019 | 443 | 0.320 |
Why?
| | Retrospective Studies | 17 | 2023 | 12978 | 0.310 |
Why?
| | Infant | 12 | 2021 | 8293 | 0.310 |
Why?
| | Elastin | 6 | 2015 | 77 | 0.300 |
Why?
| | Case-Control Studies | 13 | 2019 | 3171 | 0.300 |
Why?
| | Cardiac Output | 4 | 2020 | 147 | 0.290 |
Why?
| | Heart Septal Defects | 1 | 2006 | 10 | 0.290 |
Why?
| | Vasomotor System | 1 | 2006 | 47 | 0.280 |
Why?
| | Ventricular Dysfunction, Left | 3 | 2019 | 374 | 0.280 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2021 | 1137 | 0.280 |
Why?
| | Regional Blood Flow | 4 | 2021 | 418 | 0.260 |
Why?
| | Follow-Up Studies | 5 | 2021 | 4596 | 0.260 |
Why?
| | Reproducibility of Results | 7 | 2018 | 2874 | 0.250 |
Why?
| | Tomography, X-Ray Computed | 2 | 2018 | 2436 | 0.250 |
Why?
| | Child, Preschool | 13 | 2021 | 9491 | 0.250 |
Why?
| | Heart Transplantation | 2 | 2023 | 671 | 0.250 |
Why?
| | Arteries | 2 | 2018 | 250 | 0.240 |
Why?
| | Models, Biological | 1 | 2011 | 1715 | 0.240 |
Why?
| | Animals | 21 | 2023 | 33381 | 0.230 |
Why?
| | Myocardium | 3 | 2023 | 970 | 0.230 |
Why?
| | Patient-Specific Modeling | 3 | 2020 | 37 | 0.230 |
Why?
| | Electrocardiography | 2 | 2023 | 556 | 0.220 |
Why?
| | Materials Testing | 2 | 2017 | 359 | 0.220 |
Why?
| | Prospective Studies | 9 | 2021 | 6471 | 0.220 |
Why?
| | Umbilical Arteries | 2 | 2013 | 38 | 0.220 |
Why?
| | Endothelial Cells | 3 | 2023 | 732 | 0.220 |
Why?
| | Severity of Illness Index | 6 | 2019 | 2674 | 0.210 |
Why?
| | Perfusion Imaging | 2 | 2019 | 44 | 0.210 |
Why?
| | Assisted Circulation | 1 | 2021 | 24 | 0.200 |
Why?
| | Sensitivity and Specificity | 4 | 2018 | 1795 | 0.200 |
Why?
| | Arrhythmias, Cardiac | 1 | 2023 | 277 | 0.200 |
Why?
| | Glycopeptides | 1 | 2021 | 58 | 0.190 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2021 | 106 | 0.190 |
Why?
| | Cardiovascular Diseases | 2 | 2023 | 1798 | 0.190 |
Why?
| | Disease Models, Animal | 7 | 2023 | 3730 | 0.180 |
Why?
| | Ventricular Pressure | 1 | 2019 | 41 | 0.180 |
Why?
| | Peptide Fragments | 2 | 2021 | 702 | 0.170 |
Why?
| | Age Factors | 5 | 2019 | 2995 | 0.170 |
Why?
| | Lung | 5 | 2015 | 3664 | 0.170 |
Why?
| | Sheep | 4 | 2014 | 764 | 0.170 |
Why?
| | Marfan Syndrome | 1 | 2018 | 42 | 0.170 |
Why?
| | Prognosis | 5 | 2019 | 3443 | 0.160 |
Why?
| | Neuroendocrine Cells | 1 | 2018 | 30 | 0.160 |
Why?
| | Cardiorespiratory Fitness | 1 | 2018 | 39 | 0.160 |
Why?
| | Turner Syndrome | 1 | 2018 | 50 | 0.160 |
Why?
| | Microcirculation | 2 | 2016 | 155 | 0.160 |
Why?
| | Thermodilution | 1 | 2017 | 13 | 0.160 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2018 | 75 | 0.160 |
Why?
| | Echocardiography, Doppler | 1 | 2018 | 95 | 0.160 |
Why?
| | Models, Theoretical | 2 | 2013 | 556 | 0.150 |
Why?
| | Aortic Coarctation | 1 | 2018 | 57 | 0.150 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2018 | 77 | 0.150 |
Why?
| | ROC Curve | 2 | 2015 | 473 | 0.150 |
Why?
| | Shear Strength | 3 | 2018 | 55 | 0.150 |
Why?
| | Algorithms | 4 | 2019 | 1541 | 0.150 |
Why?
| | Hemorheology | 1 | 2016 | 20 | 0.140 |
Why?
| | Pressure | 2 | 2019 | 226 | 0.140 |
Why?
| | Arterioles | 1 | 2016 | 46 | 0.140 |
Why?
| | Glycocalyx | 1 | 2016 | 23 | 0.140 |
Why?
| | Physical Conditioning, Animal | 1 | 2018 | 204 | 0.140 |
Why?
| | Biomimetic Materials | 1 | 2017 | 66 | 0.140 |
Why?
| | Adaptation, Physiological | 2 | 2018 | 502 | 0.140 |
Why?
| | Capillaries | 1 | 2016 | 103 | 0.140 |
Why?
| | Nitric Oxide | 1 | 2021 | 892 | 0.130 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2022 | 3360 | 0.130 |
Why?
| | Young Adult | 8 | 2021 | 10793 | 0.130 |
Why?
| | Principal Component Analysis | 3 | 2023 | 180 | 0.130 |
Why?
| | Compliance | 2 | 2012 | 44 | 0.130 |
Why?
| | Familial Primary Pulmonary Hypertension | 4 | 2021 | 193 | 0.130 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2017 | 236 | 0.130 |
Why?
| | Oxygen Consumption | 1 | 2017 | 586 | 0.130 |
Why?
| | Software | 2 | 2023 | 613 | 0.130 |
Why?
| | Area Under Curve | 1 | 2015 | 296 | 0.130 |
Why?
| | Tissue Scaffolds | 1 | 2017 | 184 | 0.130 |
Why?
| | Animals, Newborn | 3 | 2015 | 806 | 0.130 |
Why?
| | Signal Processing, Computer-Assisted | 2 | 2023 | 140 | 0.130 |
Why?
| | Endotoxins | 1 | 2015 | 234 | 0.120 |
Why?
| | Pulsatile Flow | 1 | 2014 | 54 | 0.120 |
Why?
| | Adventitia | 1 | 2014 | 39 | 0.120 |
Why?
| | Bronchi | 1 | 2015 | 242 | 0.120 |
Why?
| | Contrast Media | 1 | 2017 | 373 | 0.120 |
Why?
| | Image Enhancement | 1 | 2015 | 181 | 0.120 |
Why?
| | Cardiography, Impedance | 1 | 2013 | 6 | 0.120 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2017 | 454 | 0.120 |
Why?
| | Aorta, Abdominal | 1 | 2013 | 40 | 0.120 |
Why?
| | Oscillometry | 1 | 2013 | 34 | 0.120 |
Why?
| | Time Factors | 4 | 2021 | 6412 | 0.120 |
Why?
| | Toll-Like Receptor 2 | 1 | 2014 | 127 | 0.120 |
Why?
| | Middle Aged | 9 | 2021 | 27617 | 0.120 |
Why?
| | Pilot Projects | 3 | 2021 | 1419 | 0.120 |
Why?
| | Precision Medicine | 1 | 2017 | 363 | 0.120 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 2014 | 132 | 0.120 |
Why?
| | Lung Diseases, Interstitial | 1 | 2018 | 464 | 0.110 |
Why?
| | Ultrasonography, Doppler, Color | 2 | 2010 | 35 | 0.110 |
Why?
| | Feasibility Studies | 1 | 2015 | 749 | 0.110 |
Why?
| | Polymers | 1 | 2017 | 482 | 0.110 |
Why?
| | Vitamin D | 1 | 2015 | 354 | 0.110 |
Why?
| | Equipment Design | 1 | 2014 | 519 | 0.100 |
Why?
| | Models, Statistical | 1 | 2015 | 636 | 0.100 |
Why?
| | Reference Values | 2 | 2017 | 774 | 0.100 |
Why?
| | Elastic Tissue | 1 | 2011 | 8 | 0.100 |
Why?
| | Fibrillar Collagens | 1 | 2011 | 12 | 0.100 |
Why?
| | Pregnancy | 5 | 2015 | 5690 | 0.100 |
Why?
| | Linear Models | 2 | 2018 | 827 | 0.100 |
Why?
| | Biomarkers | 2 | 2021 | 3588 | 0.100 |
Why?
| | MicroRNAs | 1 | 2017 | 637 | 0.100 |
Why?
| | Pre-Eclampsia | 1 | 2013 | 183 | 0.090 |
Why?
| | Ultrasonography, Doppler, Pulsed | 1 | 2010 | 6 | 0.090 |
Why?
| | NF-kappa B | 1 | 2014 | 670 | 0.090 |
Why?
| | Biomechanical Phenomena | 4 | 2017 | 683 | 0.090 |
Why?
| | Exercise | 1 | 2020 | 1657 | 0.090 |
Why?
| | Uncertainty | 1 | 2010 | 101 | 0.090 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2023 | 2174 | 0.090 |
Why?
| | Microbubbles | 1 | 2009 | 38 | 0.090 |
Why?
| | Ventricular Remodeling | 2 | 2023 | 229 | 0.090 |
Why?
| | Vasodilator Agents | 1 | 2011 | 328 | 0.090 |
Why?
| | Ultrasonics | 1 | 2009 | 53 | 0.090 |
Why?
| | Hypertrophy, Right Ventricular | 2 | 2023 | 146 | 0.090 |
Why?
| | Postoperative Complications | 1 | 2020 | 2235 | 0.080 |
Why?
| | Fibrosis | 2 | 2021 | 483 | 0.080 |
Why?
| | Mechanotransduction, Cellular | 2 | 2023 | 101 | 0.080 |
Why?
| | Risk Factors | 3 | 2017 | 9000 | 0.080 |
Why?
| | Ultrasonography, Doppler | 1 | 2008 | 104 | 0.080 |
Why?
| | Logistic Models | 2 | 2015 | 1901 | 0.080 |
Why?
| | Reference Standards | 1 | 2008 | 176 | 0.080 |
Why?
| | Electric Impedance | 1 | 2007 | 101 | 0.080 |
Why?
| | Probability | 1 | 2007 | 305 | 0.070 |
Why?
| | Disease Progression | 3 | 2018 | 2490 | 0.060 |
Why?
| | Treatment Outcome | 2 | 2018 | 9342 | 0.060 |
Why?
| | Chronic Disease | 1 | 2010 | 1636 | 0.060 |
Why?
| | Hypertension | 2 | 2012 | 1203 | 0.060 |
Why?
| | Bromocriptine | 1 | 2022 | 28 | 0.060 |
Why?
| | Glycosaminoglycans | 2 | 2013 | 78 | 0.060 |
Why?
| | Vasodilation | 2 | 2018 | 457 | 0.060 |
Why?
| | Cross-Sectional Studies | 3 | 2019 | 4552 | 0.060 |
Why?
| | Rats | 3 | 2018 | 5392 | 0.050 |
Why?
| | Matrix Metalloproteinases, Secreted | 1 | 2021 | 10 | 0.050 |
Why?
| | Long Term Adverse Effects | 1 | 2021 | 10 | 0.050 |
Why?
| | ADAMTS4 Protein | 1 | 2021 | 15 | 0.050 |
Why?
| | Heart Murmurs | 1 | 2021 | 12 | 0.050 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2021 | 19 | 0.050 |
Why?
| | Cross-Over Studies | 1 | 2022 | 456 | 0.050 |
Why?
| | Vascular Remodeling | 1 | 2021 | 152 | 0.050 |
Why?
| | Coronary Circulation | 1 | 2020 | 121 | 0.050 |
Why?
| | Dimensional Measurement Accuracy | 1 | 2019 | 12 | 0.040 |
Why?
| | Overweight | 1 | 2023 | 502 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2021 | 656 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 409 | 0.040 |
Why?
| | Pediatrics | 1 | 2006 | 985 | 0.040 |
Why?
| | Rabbits | 1 | 2019 | 780 | 0.040 |
Why?
| | Diastole | 1 | 2018 | 145 | 0.040 |
Why?
| | Comparative Effectiveness Research | 1 | 2019 | 132 | 0.040 |
Why?
| | Heart Failure, Diastolic | 1 | 2018 | 21 | 0.040 |
Why?
| | Mitochondria, Heart | 1 | 2018 | 76 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 2 | 2015 | 2478 | 0.040 |
Why?
| | Exercise Test | 1 | 2020 | 551 | 0.040 |
Why?
| | Hyperplasia | 1 | 2018 | 170 | 0.040 |
Why?
| | Electrophysiologic Techniques, Cardiac | 1 | 2018 | 72 | 0.040 |
Why?
| | Postoperative Period | 1 | 2018 | 309 | 0.040 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 109 | 0.040 |
Why?
| | Rare Diseases | 1 | 2018 | 113 | 0.040 |
Why?
| | Activities of Daily Living | 1 | 2020 | 354 | 0.040 |
Why?
| | Aftercare | 1 | 2019 | 194 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2018 | 399 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2021 | 1691 | 0.040 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 403 | 0.040 |
Why?
| | Dilatation, Pathologic | 1 | 2017 | 56 | 0.040 |
Why?
| | Heart Valve Diseases | 1 | 2018 | 135 | 0.040 |
Why?
| | Proteomics | 1 | 2023 | 876 | 0.040 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 101 | 0.040 |
Why?
| | Vasoconstriction | 1 | 2018 | 213 | 0.040 |
Why?
| | Education | 1 | 2017 | 105 | 0.040 |
Why?
| | Exercise Tolerance | 1 | 2018 | 233 | 0.040 |
Why?
| | Blood Viscosity | 1 | 2016 | 19 | 0.040 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 278 | 0.040 |
Why?
| | Heart | 1 | 2020 | 631 | 0.030 |
Why?
| | Capillary Permeability | 1 | 2016 | 140 | 0.030 |
Why?
| | Respiratory Physiological Phenomena | 1 | 2015 | 31 | 0.030 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2016 | 75 | 0.030 |
Why?
| | Aged | 3 | 2019 | 19657 | 0.030 |
Why?
| | Postoperative Care | 1 | 2017 | 237 | 0.030 |
Why?
| | Risk | 1 | 2018 | 853 | 0.030 |
Why?
| | Myocardial Ischemia | 1 | 2017 | 251 | 0.030 |
Why?
| | Demography | 1 | 2015 | 274 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1293 | 0.030 |
Why?
| | Aortic Valve | 1 | 2018 | 401 | 0.030 |
Why?
| | Hematocrit | 1 | 2014 | 91 | 0.030 |
Why?
| | Tricuspid Valve | 1 | 2014 | 23 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2014 | 220 | 0.030 |
Why?
| | Phosphatidylcholines | 1 | 2014 | 133 | 0.030 |
Why?
| | Cardiomyopathies | 1 | 2017 | 299 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 311 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2014 | 5255 | 0.030 |
Why?
| | Altitude Sickness | 1 | 2014 | 163 | 0.030 |
Why?
| | Survival Rate | 1 | 2017 | 1720 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 564 | 0.030 |
Why?
| | Mice | 2 | 2021 | 15520 | 0.030 |
Why?
| | Toll-Like Receptor 4 | 1 | 2014 | 330 | 0.030 |
Why?
| | Up-Regulation | 1 | 2014 | 872 | 0.020 |
Why?
| | Erythrocytes | 1 | 2016 | 641 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 2014 | 505 | 0.020 |
Why?
| | Obesity | 1 | 2023 | 2746 | 0.020 |
Why?
| | Species Specificity | 1 | 2011 | 565 | 0.020 |
Why?
| | Gestational Age | 1 | 2012 | 765 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4077 | 0.020 |
Why?
| | Hyperbaric Oxygenation | 1 | 2008 | 39 | 0.020 |
Why?
| | Tunica Media | 1 | 2007 | 36 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2008 | 522 | 0.020 |
Why?
| | Finite Element Analysis | 1 | 2007 | 70 | 0.020 |
Why?
| | Tunica Intima | 1 | 2007 | 78 | 0.020 |
Why?
| | Protein Conformation | 1 | 2008 | 848 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2012 | 2275 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2014 | 4908 | 0.020 |
Why?
| | Colorado | 1 | 2014 | 4196 | 0.020 |
Why?
| | Radiography | 1 | 2007 | 861 | 0.020 |
Why?
| | Research Design | 1 | 2010 | 969 | 0.010 |
Why?
| | Inflammation | 1 | 2014 | 2566 | 0.010 |
Why?
| | Adult | 2 | 2017 | 31512 | 0.010 |
Why?
| | United States | 1 | 2017 | 12555 | 0.010 |
Why?
|
|
Hunter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|